A recent study published in June emphasized the urgent need for Tamiflu stock with additional antiviral drugs including zanamivir (Relenza) based on an evaluation of the performance of these drugs in the scenario that the 2009 H1N1 ‘Swine Flu' neuraminidase (NA) were to acquire the tamiflu-resistance mutation which is currently widespread in seasonal H1N1 strains. __